Simultaneous quantification of SPIO and gadolinium contrast agents using MR fingerprinting

被引:4
作者
Marriott, Anna [1 ,2 ]
Bowen, Chris [1 ,2 ]
Rioux, James [1 ,2 ]
Brewer, Kimberly [1 ,2 ]
机构
[1] Biomed Translat Imaging Ctr Biot, Halifax, NS, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
MR fingerprinting; T-2*; R-2*; Gadolinium; SPIO; Preclinical; IRON-OXIDE; T-1;
D O I
10.1016/j.mri.2021.03.017
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Develop a magnetic resonance fingerprinting (MRF) methodology with R-2* quantification, intended for use with simultaneous contrast agent concentration mapping, particularly gadolinium (Gd) and iron labelled CD8+ T cells. Methods: Variable-density spiral SSFP MRF was used, modified to allow variable TE, and with an exp.(-TE.R-2*) dictionary modulation. In vitro phantoms containing SPIO labelled cells and/or gadolinium were used to validate parameter maps, probe undersampling capacity, and verify dual quantification capabilities. A C57BL/6 mouse was imaged using MRF to demonstrate acceptable in vivo resolution and signal at 8 x undersampling necessary for a 25-min scan. Results: Strong agreement was found between conventional and MRF-derived values for R1, R2, and R-2*. Expanded MRF allowed quantification of iron-loaded CD8+ T cells. Results were robust to 8x undersampling and enabled recreation of relaxation profiles for both a Gd agent and iron labelled cells simultaneously. In vivo data demonstrated sufficient SNR in undersampled data for parameter mapping to visualise key features. Conclusion: MRF can be expanded to include R1, R2, and R-2* mapping required for simultaneous quantification of gadolinium and SPIO in vitro, allowing for potential implementation of a variety of future in vivo studies using dual MR contrast agents, including molecular imaging of labelled cells.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 50 条
[41]   Manganese-Based Contrast Agents as a Replacement for Gadolinium [J].
Davis, Katie A. ;
Lazar, Bruce .
RADIOLOGIC TECHNOLOGY, 2021, 93 (01) :36-45
[42]   Modulating the relaxivity of hyperpolarized substrates with gadolinium contrast agents [J].
Gabellieri, Cristina ;
Leach, Martin O. ;
Eykyn, Thomas R. .
CONTRAST MEDIA & MOLECULAR IMAGING, 2009, 4 (03) :143-147
[43]   Quantification of water exchange across the blood-brain barrier using noncontrast MR fingerprinting [J].
Thomson, Emma L. ;
Powell, Elizabeth ;
Wheeler-Kingshott, Claudia A. M. Gandini ;
Parker, Geoff J. M. .
MAGNETIC RESONANCE IN MEDICINE, 2024, 92 (04) :1392-1403
[44]   An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis [J].
Bartolini, ME ;
Pekar, J ;
Chettle, DR ;
McNeill, F ;
Scott, A ;
Sykes, J ;
Prato, FS ;
Moran, GR .
MAGNETIC RESONANCE IMAGING, 2003, 21 (05) :541-544
[45]   Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T [J].
Wang, Carolyn Lee ;
Chea, Yen Wei ;
Boll, Daniel T. ;
Samei, Ehsan ;
Neville, Amy M. ;
Dale, Brian M. ;
Merkle, Elmar M. .
EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (02) :E1-E7
[46]   MR-angiography: the role of contrast agents [J].
Goyen, M ;
Ruehm, SG ;
Debatin, JF .
EUROPEAN JOURNAL OF RADIOLOGY, 2000, 34 (03) :247-256
[47]   USE OF MR IMAGING CONTRAST AGENTS IN THE BRAIN [J].
BRADLEY, WG ;
YUH, WTC ;
BYDDER, GM .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (01) :199-218
[48]   Tissue-specific MR contrast agents [J].
Weinmann, HJ ;
Ebert, W ;
Misselwitz, B ;
Schmitt-Willich, H .
EUROPEAN JOURNAL OF RADIOLOGY, 2003, 46 (01) :33-44
[49]   APPLICATION OF CONTRAST AGENTS IN MR IMAGING OF THE SPINE [J].
FULBRIGHT, R ;
ROSS, JS ;
SZE, G .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (01) :219-232
[50]   MR contrast agents: Physical and pharmacologic basics [J].
Lin, Shao-Pow ;
Brown, Jeffrey J. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 25 (05) :884-899